92 related articles for article (PubMed ID: 3220112)
1. Evidence that type A CCK receptors facilitate dopamine efflux in rat brain.
Vickroy TW; Bianchi BR; Kerwin JF; Kopecka H; Nadzan AM
Eur J Pharmacol; 1988 Aug; 152(3):371-2. PubMed ID: 3220112
[No Abstract] [Full Text] [Related]
2. Pharmacological and mechanistic studies of cholecystokinin-facilitated [3H]dopamine efflux from rat nucleus accumbens.
Vickroy TW; Bianchi BR
Neuropeptides; 1989 Jan; 13(1):43-50. PubMed ID: 2466220
[TBL] [Abstract][Full Text] [Related]
3. Dopamine receptor elevation by cholecystokinin.
Dumbrille-Ross A; Seeman P
Peptides; 1984; 5(6):1207-12. PubMed ID: 6531273
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitro.
Marshall FH; Barnes S; Pinnock RD; Hughes J
Br J Pharmacol; 1990 Apr; 99(4):845-8. PubMed ID: 2361176
[TBL] [Abstract][Full Text] [Related]
5. Receptor selectivity of cholecystokinin effects on mesoaccumbens dopamine neurons.
Kelland MD; Zhang J; Chiodo LA; Freeman AS
Synapse; 1991 Jun; 8(2):137-43. PubMed ID: 1882334
[TBL] [Abstract][Full Text] [Related]
6. [Effect of cholecystokinin on dopamine metabolism in the rat brain].
Kogan BM; Khristoliubova NA; Anokhin KV
Biull Eksp Biol Med; 1982 Aug; 94(8):42-3. PubMed ID: 7126854
[TBL] [Abstract][Full Text] [Related]
7. What we know and what we need to know about the role of endogenous CCK in psychostimulant sensitization.
Beinfeld MC
Life Sci; 2003 Jun; 73(6):643-54. PubMed ID: 12801586
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection.
Fuxe K; Andersson K; Locatelli V; Agnati LF; Hökfelt T; Skirboll L; Mutt V
Eur J Pharmacol; 1980 Oct; 67(2-3):329-31. PubMed ID: 7461038
[No Abstract] [Full Text] [Related]
9. Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors.
Rodriguez M; Lignon MF; Galas MC; Amblard M; Martinez J
Mol Pharmacol; 1990 Sep; 38(3):333-41. PubMed ID: 1698251
[TBL] [Abstract][Full Text] [Related]
10. Coactivation of dopamine D1 and D2 receptors increases the affinity of cholecystokinin-8 receptors in membranes from post-mortem human caudate-putamen.
von Euler G; Mailleux P; von Euler M; Schiffmann SN; Vanderhaeghen JJ; Fuxe K
Brain Res; 1992 Jul; 584(1-2):157-62. PubMed ID: 1325243
[TBL] [Abstract][Full Text] [Related]
11. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens.
Lane RF; Blaha CD; Phillips AG
Brain Res; 1986 Nov; 397(1):200-4. PubMed ID: 3801862
[TBL] [Abstract][Full Text] [Related]
12. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
Crawley JN; Stivers JA; Hommer DW; Skirboll LR; Paul SM
J Pharmacol Exp Ther; 1986 Feb; 236(2):320-30. PubMed ID: 3003339
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological activity of cholecystokinin analogues modified in the Met28-Gly29 region.
Mendre C; Rodriguez M; Lignon MF; Galas MC; Gueudet C; Worms P; Martinez J
Eur J Pharmacol; 1990 Sep; 186(2-3):213-22. PubMed ID: 1705230
[TBL] [Abstract][Full Text] [Related]
14. Receptor binding of cholecystokinin analogues in isolated rat pancreatic acini.
Doi R; Hosotani R; Inoue K; Fujii N; Yajima H; Rayford PL; Tobe T
Biochem Biophys Res Commun; 1990 Jan; 166(1):286-92. PubMed ID: 2302208
[TBL] [Abstract][Full Text] [Related]
15. Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons.
White FJ; Wang RY
Brain Res; 1984 May; 300(1):161-6. PubMed ID: 6145498
[TBL] [Abstract][Full Text] [Related]
16. Modulation of cholecystokinin release from posterior nucleus accumbens by D-2 dopamine receptor.
Martin JR; Beinfeld MC; Wang RY
Brain Res; 1986 Nov; 397(2):253-8. PubMed ID: 2948613
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin combined with serotonin in the hypothalamus limits accumbens dopamine release while increasing acetylcholine: a possible satiation mechanism.
Helm KA; Rada P; Hoebel BG
Brain Res; 2003 Feb; 963(1-2):290-7. PubMed ID: 12560135
[TBL] [Abstract][Full Text] [Related]
18. [Study of induced effects by selective CCKB agonists cholecystokinin in the nociception and behavior in rodents].
Dauge V; Derrien M; Durieux C; Noble F; Corringer PJ; Roques BP
Therapie; 1992 Nov; 47(6):531-9. PubMed ID: 1301645
[TBL] [Abstract][Full Text] [Related]
19. Mother-Infant Interactions in Rats Lacking CCK(A) Receptors.
Lavi-Avnon Y; Malkesman O; Hurwitz I; Weller A
Behav Neurosci; 2004 Apr; 118(2):282-9. PubMed ID: 15113252
[TBL] [Abstract][Full Text] [Related]
20. In vivo release of dopamine in the nucleus accumbens of the rat: modulation by cholecystokinin.
Voigt MM; Wang RY
Brain Res; 1984 Mar; 296(1):189-93. PubMed ID: 6324955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
